Zsquare, a leading developer of high-performance, single-use endoscopes, has raised $15M in financing for the soft launch of its disruptive single-use ENT endoscope and further R&D to expand potential use in other indications. The soft launch is planned following FDA clearance expected in the third quarter of 2022.

Zsquare, a privately held medical device company with headquarters in Israel, develops cost-effective, high-performance, single-use endoscopes to enable access to unserved indications, improve performance in current practices, and solve the industry's cross-contamination problem.
Logo - https://mma.prnewswire.com/media/1136770/Zsquare_Logo.jpg
Media Contact: Chen Goldstein+972-524258183 chen.goldstein@zsquaremedical.com
SOURCE Zsquare

Zsquare Secures A $15M Round With Its Lead Investor

Description

Company Information

Funding Insights

Zsquare Secures A $15M Round With Its Lead Investor

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Company Information